Sarantis Health & Care Division successfully participated in the 16th Health Expo, one of Greece’s leading exhibitions in the Health and Care sector. The event, held on February 15-16 at the Megaron Athens International Conference Centre, brought together professionals and industry leaders, reaffirming the dynamic growth and significance of the health and care sector in Greece and beyond.
Sarantis Group will release its FY 2024 Annual Financial Results and Annual Financial Report, as follows: Wednesday, March 12th 2025 following Athens Exchange Market closing – Results and Report Release, which will be available at the Athens Stock Exchange website (www.
Sarantis Group and the Tesori d’Oriente team, in collaboration with Allbright Advertising, created the exciting event “Tesori d’Oriente Express” — a groundbreaking experience that captivated guests and earned significant accolades at the 2025 Event Awards.
The company GR. SARANTIS S.A. announces, according to L.3556/2007 and the provisions of the Regulation (EU) No 596/2014 of the European Parliament and of the Council, that Mr. Kyriakos Sarantis, Chairman of the Board of Directors and Executive Member of the Board, proceeded on February 5th of 2025 with the purchase of 30,112 common shares in total at the average price of 11.
The company GR. SARANTIS S.A. announces that Mrs. Aikaterini Saranti proceeded on February 7th of 2025 with the purchase of 2,964 common shares in total at the average price of 11.31 euro per share. This announcement is issued with a purpose of providing investors with comprehensive information, without being required by the regulatory framework, as Mrs.
SARANTIS S.A. (“the Company”) announces that, in implementation of the resolution of the Shareholders’ Annual General Meeting dated April 23rd 2024, the Company proceeded on February 5th 2025 with the purchase of 4,714 own shares at the average price of 11.
SARANTIS S.A. (“the Company”) announces that, in implementation of the resolution of the Shareholders’ Annual General Meeting dated April 23rd 2024, the Company proceeded on February 4th 2025 with the purchase of 2,119 own shares at the average price of 11.
SARANTIS S.A. (“the Company”) announces that, in implementation of the resolution of the Shareholders’ Annual General Meeting dated April 23rd 2024, the Company proceeded on February 3rd 2025 with the purchase of 2,000 own shares at the average price of 11.